Inhibition of mammalian target of rapamycin signaling potentiates the effects of all‐trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Our study explored the drug interaction of all‐tran s retinoic acid (ATRA) and RAD001 (everolimus), the inhibitor of mammalian target of rapamycin complex 1 (mTORC1), in acute myelogenous leukemia (AML) NB4 and HL60 cells. RAD001 (10 nM) significantly enhanced the ATRA‐induced growth arrest and differentiation of these cells, as measured by colony‐forming assay and cell cycle analysis, and expression of CD11b cell surface antigen and nitroblue tetrazolium reduction, respectively. ATRA (0.1–1 μM) upregulated levels of RTP801, a negative regulator of mTORC1, and inhibited mTORC1 signaling as assessed by measurement of the levels of p‐p70S6K and p‐4E‐BP1 in HL60 and NB4 cells. ATRA (0.1–1 μM) in combination with RAD001 (10 nM) strikingly downregulated the levels of p‐70S6K and p‐4E‐BP1 without affecting the total amount of these proteins. Notably, RAD001 (10 nM) significantly augmented ATRA‐induced expression of CCAAT/enhancer‐binding protein ε (C/EBPε) and p27kip1 and downregulated levels of c‐Myc in these cells. Furthermore, RAD001 (5 mg/kg) enhanced the ability of ATRA (10 mg/kg) to inhibit the proliferation of HL60 cells growing as tumor xenografts in immune‐deficient nude mice. Taken together, concomitant blockade of the RA and mTORC1 signaling may be a promising treatment strategy for individuals with AML. © 2009 UICC
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., & Kaelin, W. G. (2004) · Genes & Development · doi:10.1101/gad.1256804 · Cited by 1,384
Regulation of mTOR and Cell Growth in Response to Energy Stress by REDD1
Sofer, A., Lei, K., Johannessen, C. M., & Ellisen, L. W. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.5834-5845.2005 · Cited by 449
Yamanaka, R., Barlow, C., Lekstrom-Himes, J., Castilla, L. H., Liu, P. P., Eckhaus, M., Decker, T., Wynshaw-Boris, A., & Xanthopoulos, K. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13187 · Cited by 383 · cited 1×
“C/EBPe ‘‘knock-out’’ (deletional) mice have incomplete maturation of their granulocytes, and the cells do not have specific granule proteins.(3) Furthermore, forced expression of C/EBPe in U937 myeloblasts can induce these cells to differentiate to more mature granulocytes.”
BackgroundCorradetti, M. N., Inoki, K., & Guan, K.-L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c400557200 · Cited by 237
Park, D. J., Chumakov, A. M., Vuong, P. T., Chih, D. Y., Gombart, A. F., Miller, W. H., & Koeffler, H. P. (1999) · Journal of Clinical Investigation · doi:10.1172/jci2887 · Cited by 187
Self-citationWang, Z., Malone, M. H., Thomenius, M. J., Zhong, F., Xu, F., & Distelhorst, C. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303723200 · Cited by 144
Cited by
Plzf Regulates Germline Progenitor Self-Renewal by Opposing mTORC1
Hobbs, R. M., Seandel, M., Falciatori, I., Rafii, S., & Pandolfi, P. P. (2010) · Cell · doi:10.1016/j.cell.2010.06.041 · Cited by 273
Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein
Isakson, P., Bjørås, M., Bøe, S. O., & Simonsen, A. (2010) · Blood · doi:10.1182/blood-2010-01-261040 · Cited by 268
Unlocking the potential of retinoic acid in anticancer therapy
Schenk, T., Stengel, S., & Zelent, A. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.412 · Cited by 160
Trocoli, A., Mathieu, J., Priault, M., Reiffers, J., Souquère, S., Pierron, G., Besançon, F., & Djavaheri-Mergny, M. (2011) · Autophagy · doi:10.4161/auto.7.10.16623 · Cited by 54
WIPI-dependent autophagy during neutrophil differentiation of NB4 acute promyelocytic leukemia cells
Brigger, D., Proikas-Cezanne, T., & Tschan, M. P. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.261 · Cited by 48
Metadata
- Authors
- Nishioka, C., Ikezoe, T., Yang, J., Gery, S., Koeffler, H. P., & Yokoyama, A.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2009-06-08
- Volume
- 125
- Issue
- 7
- Pages
- 1710-1720
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1971636850
- Cited by
- 43
- References
- 6
- FWCI
- 2.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of mammalian target of rapamycin signaling potentiates the effects of all‐trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells. https://app.cochat.ai/papers/10.1002/ijc.24472
- The paper
- Nishioka, C., Ikezoe, T., Yang, J., Gery, S., Koeffler, H. P., & Yokoyama, A. (2009). Inhibition of mammalian target of rapamycin signaling potentiates the effects of all‐trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells. International Journal of Cancer. https://doi.org/10.1002/ijc.24472
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.